News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This is one of the most important articles of the year. It opens the door for improving response to immunotherapies in brain tumors.


Posted on: 11/22/2018

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740